GWSA
EDSA icon

Global Wealth Strategies & Associates’s Edesa Biotech EDSA Stock Holding History

Global Wealth Strategies & Associates’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7
Closed -$32 – 362
2023
Q4 		$32 Buy
+7
New +$27 ﹤0.01% 319

Other funds holding EDSA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global Wealth Strategies & Associates's EDSA Position: Q1 2024 in Review

Global Wealth Strategies & Associates sold out of Edesa Biotech (EDSA) in Q1 2024, closing a stake of 7 shares — an estimated $32 sold.

Global Wealth Strategies & Associates first reported a position in EDSA in Q4 2023 and held it in 1 quarter. The position peaked at $32 in Q4 2023. 17 funds tracked by Wall St. Rank hold EDSA as of Q1 2024.

  • Global Wealth Strategies & Associates reported no remaining Edesa Biotech position as of Q1 2024 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 7 Edesa Biotech shares in Q1 2024, an estimated $32.
  • Global Wealth Strategies & Associates first reported a position in Edesa Biotech in Q4 2023 and held it in 1 quarter.
  • Global Wealth Strategies & Associates's Edesa Biotech position peaked at $32 in Q4 2023.
  • 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2024.

Based on Global Wealth Strategies & Associates's 13F filing for Q1 2024, filed 1 Apr 2024.